2001
DOI: 10.1016/s0022-1759(01)00462-8
|View full text |Cite
|
Sign up to set email alerts
|

Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
40
0

Year Published

2002
2002
2015
2015

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 61 publications
(40 citation statements)
references
References 36 publications
0
40
0
Order By: Relevance
“…Colonies were picked up, and E. coli cells harboring phagemid were grown in 2ϫYT medium containing 100 g of ampicillin/ ml, 0.05% glucose, and 1 mM IPTG (isopropyl-␤-D-thiogalactopyranoside) at 30°C overnight. The Fab-cp3 form of MAb was secreted into medium (27). Culture supernatants containing Fab-cp3 molecules were subjected to enzyme-linked immunosorbent assay (ELISA) against 12 H3N2 strains and an H1N1 NC99 strain of influenza viruses.…”
mentioning
confidence: 99%
“…Colonies were picked up, and E. coli cells harboring phagemid were grown in 2ϫYT medium containing 100 g of ampicillin/ ml, 0.05% glucose, and 1 mM IPTG (isopropyl-␤-D-thiogalactopyranoside) at 30°C overnight. The Fab-cp3 form of MAb was secreted into medium (27). Culture supernatants containing Fab-cp3 molecules were subjected to enzyme-linked immunosorbent assay (ELISA) against 12 H3N2 strains and an H1N1 NC99 strain of influenza viruses.…”
mentioning
confidence: 99%
“…Colonies were picked up, and the E. coli colonies harboring the phagemid were grown in 2ϫ yeast extract-tryptophan (YT) medium containing 100 g/ml ampicillin, 0.05% glucose, and 1 mM isopropyl-␤-D-thiogalactopyranoside at 30°C overnight. The Fab-cp3 form of Ab was secreted into the medium (13). The culture supernatants containing Fab-cp3 molecules were subjected to enzymelinked immunosorbent assay (ELISA) against various H3 strains of influenza viruses and an H1 strain of influenza virus.…”
mentioning
confidence: 99%
“…In addition, scFvs are typically used for antibody selection and engineering, in which many scFvs (10 to hundreds) often are simultaneously isolated (7, 11). Thus, fusion to GFP can enable rapid assessment of scFv binding and specificity properties without the requirement for chemical modification and the difficulties associated with losses in activity (2,8,18,20,21,29).The key to an effective scFv-GFP fusion protein platform is the ability to rapidly take an identified scFv or collection of scFvs and produce them efficiently as GFP fusion proteins in an appropriate host. Expression of scFv-GFP fusion proteins using bacteria has resulted in limited success, with yields of 100 to 200 g/liter, whether periplasmic secretion or inclusion body methods were used (2,8,18,20,21).…”
mentioning
confidence: 99%